SERPINE1 and neoplasm: Classification and regression-tree analysis method (CART) was used to establish the best cut-off to distinguish two groups of patients depending on SERPINE1 mRNA tumor levels and their probability of relapse (SERPINE1-mRNA level < or > 0.8).